Works matching IS 15309932 AND DT 2014 AND VI 15 AND IP 1


Results: 25
    1

    Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape.

    Published in:
    AAPS PharmSciTech, 2014, v. 15, n. 1, p. 237, doi. 10.1208/s12249-013-0061-z
    By:
    • Alsante, Karen M.;
    • Huynh-Ba, Kim C.;
    • Baertschi, Steven W.;
    • Reed, Robert A.;
    • Landis, Margaret S.;
    • Furness, Scott;
    • Olsen, Bernard;
    • Mowery, Mark;
    • Russo, Karen;
    • Iser, Robert;
    • Stephenson, Gregory A.;
    • Jansen, Patrick
    Publication type:
    Article
    2
    3
    4

    Topical Formulations Containing Pimenta pseudocaryophyllus Extract: In Vitro Antioxidant Activity and In Vivo Efficacy Against UV-B-Induced Oxidative Stress.

    Published in:
    AAPS PharmSciTech, 2014, v. 15, n. 1, p. 86, doi. 10.1208/s12249-013-0049-8
    By:
    • Campanini, Marcela Z.;
    • Custódio, Dayana L.;
    • Ivan, Ana L. M.;
    • Martins, Sarah M.;
    • Paranzini, Maria J. R.;
    • Martinez, Renata M.;
    • Verri Jr., Waldiceu A.;
    • Vicentini, Fabiana T. M. C.;
    • Arakawa, Nilton S.;
    • de J. Faria, Terezinha;
    • Baracat, Marcela M.;
    • Casagrande, Rúbia;
    • Georgetti, Sandra R.
    Publication type:
    Article
    5
    6
    7
    8

    Quality-by-Design: Are We There Yet?

    Published in:
    AAPS PharmSciTech, 2014, v. 15, n. 1, p. 140, doi. 10.1208/s12249-013-0043-1
    By:
    • Cook, Jack;
    • Cruañes, Maria T.;
    • Gupta, Manish;
    • Riley, Steve;
    • Crison, John
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 1: Predicting Degradation Related Impurities and Impurity Considerations for Pharmaceutical Dosage Forms.

    Published in:
    AAPS PharmSciTech, 2014, v. 15, n. 1, p. 198, doi. 10.1208/s12249-013-0047-x
    By:
    • Alsante, Karen M.;
    • Kim Huynh-Ba;
    • Baertschi, Steven W.;
    • Reed, Robert A.;
    • Landis, Margaret S.;
    • Kleinman, Mark H.;
    • Foti, Christopher;
    • Rao, Venkatramana M.;
    • Meers, Paul;
    • Abend, Andreas;
    • Reynolds, Daniel W.;
    • Joshi, Biren K.
    Publication type:
    Article
    24
    25